Terms & Conditions
Last updated: May 1, 2026
Agreement to Terms
By accessing and using novolene.com and Novolene's telehealth services, you agree to be bound by these Terms & Conditions. If you do not agree, please do not use our services.
Services Description
Novolene is a telehealth platform that connects patients with licensed medical providers who may prescribe compounded GLP-1 medications (semaglutide and tirzepatide) for weight loss. Our services include:
- Online health evaluation questionnaire
- Review by licensed medical providers
- Prescription fulfillment through FDA-regulated compounding pharmacies
- Shipment of medication to your door
- Ongoing support and care coordination
Medical Disclaimer
The evaluation provided on our website does not create a doctor-patient relationship until a licensed provider reviews your information and agrees to provide care. All prescriptions are at the discretion of the licensed medical provider. Compounded GLP-1 medications are not FDA-approved. Results may vary based on starting weight and program adherence.
Pricing and Payment
Pricing is all-inclusive and includes medication, provider access, and shipping. No membership fees. You may cancel at any time with no penalties. Payments are processed securely through Stripe.
Eligibility
You must be 18 years or older to use our services. You must provide accurate and complete health information. The licensed medical provider retains sole discretion to prescribe or decline medication based on your health profile.
Cancellation and Refunds
You may cancel your subscription at any time. Refund requests are handled on a case-by-case basis. Please contact support@novolene.com for assistance.
Limitation of Liability
Novolene acts as a platform connecting patients with licensed providers. We are not a medical practice and do not provide medical advice, diagnosis, or treatment directly. All medical decisions are made by licensed healthcare providers.
Contact
For questions about these Terms, contact us at support@novolene.com or (213) 436-1474.
